Overview

Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients

Status:
Completed
Trial end date:
2018-04-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of dexlansoprazole compared to placebo in relief of daytime and nighttime heartburn over 4 weeks in Chinese participants with symptomatic non-erosive Gastroesophageal Reflux Disease (GERD).
Phase:
Phase 3
Details
Lead Sponsor:
Takeda
Treatments:
Dexlansoprazole
Lansoprazole